Eric Hammes Biography and Net Worth

As Envista's Chief Financial Officer, Eric Hammes leads the global, corporate financial function for the organization.

Eric joins Envista from Rockwell Automation, where he served as Vice President, Corporate Financial Planning and Analysis. Prior to Rockwell, Eric spent over 25 years at 3M where he held a variety of senior financial leadership roles including SVP Controller and Chief Accounting Officer, CFO of 3M Health Care Business Group, Director Finance of 3M Orthodontic Products Division, and SVP of International Finance. In addition to his deep finance and accounting experience, Eric has held several senior operating roles including EVP of Business Transformation & IT, EVP Chief Country Governance and Services Officer, and EVP of Enterprise Operations, a role that spanned 170 manufacturing sites and over $30 billion in annual production. Eric has previously lived and worked in the US, Europe, and Asia. He received a Bachelor of Science degree in Finance from the University of Minnesota.

What is Eric D. Hammes' net worth?: The estimated net worth of Eric D. Hammes is at least $453,351.36 as of August 12th, 2024. Mr. Hammes owns 24,532 shares of Envista stock worth more than $453,351 as of October 22nd. This net worth evaluation does not reflect any other investments that Mr. Hammes may own. Learn More about Eric D. Hammes' net worth.
How do I contact Eric D. Hammes?: The corporate mailing address for Mr. Hammes and other Envista executives is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. Envista can also be reached via phone at 714-817-7000 and via email at [email protected]. Learn More on Eric D. Hammes' contact information.
Has Eric D. Hammes been buying or selling shares of Envista?: Eric D. Hammes has not been actively trading shares of Envista over the course of the past ninety days. Most recently, on Monday, August 12th, Eric D. Hammes bought 24,532 shares of Envista stock. The stock was acquired at an average cost of $16.33 per share, with a total value of $400,607.56. Following the completion of the transaction, the chief financial officer now directly owns 24,532 shares of the company's stock, valued at $400,607.56. Learn More on Eric D. Hammes' trading history.
Who are Envista's active insiders?: Envista's insider roster includes Amir Aghdaei (CEO), Curt Bludworth (Insider), Eric Conley (SVP), Eric Hammes (CFO), Jeffrey Kappler (SVP), Stephen Keller (Principal Financial Officer), Mark Nance (General Counsel), Mischa Reis (SVP), and Howard Yu (CFO). Learn More on Envista's active insiders.
Are insiders buying or selling shares of Envista?: During the last twelve months, Envista insiders bought shares 5 times. They purchased a total of 43,717 shares worth more than $817,732.21. The most recent insider tranaction occured on August, 12th when CFO Eric D Hammes bought 24,532 shares worth more than $400,607.56. Insiders at Envista own 1.3% of the company. Learn More about insider trades at Envista.
Information on this page was last updated on 8/12/2024.

Eric D. Hammes Insider Trading History at Envista

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/12/2024	Buy	24,532	$16.33	$400,607.56	24,532

Eric D. Hammes Buying and Selling Activity at Envista

Envista Company Overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Today's Range

Now: $18.66

$18.36

$18.67

50 Day Range

MA: $18.40

$16.98

$19.76

2 Week Range

Now: $18.66

$15.15

$25.64

Volume

1,878,812 shs

Average Volume

2,407,767 shs

Market Capitalization

$3.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.